|

GenaKumab Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Changchun GeneScience Pharmaceutical Co., Ltd.1

Indications

  • Active Systemic Juvenile Idiopathic Arthritis1
  • Arthritis1

Other1 trial

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.